Menu Back toSession 3 : COVID-19 Vaccine Development Strategy

NiFDS-DIA Workshop 2021: Facilitating the Development and Regulations of Covid-19 Vaccines and Treatments / Current Trends in New Drug Development and Regulations

The timing is as per Korean Time Zone


Session 3 : COVID-19 Vaccine Development Strategy

Session Chair(s)

Jaeok  Kim

Jaeok Kim

  • Associate
  • Korean Food & Drug Administration, Korea, Republic of

Speaker(s)

James  Baber, MPH

James Baber, MPH

  • Director, Clinician/Global Medical Monitor
  • Pfizer, Australia
Yu Hwa  Choi, MBA, RN

Yu Hwa Choi, MBA, RN

  • Senior Managing Director, Head of Operations Division
  • Quratis Inc., Korea, Republic of
Won Suk  Choi, MD, PhD

Won Suk Choi, MD, PhD

  • Professor, Division of Infectious Diseases, Department of Internal Medicine
  • Korea University Ansan Hospital , Korea, Republic of
SoHee  Kim, PhD

SoHee Kim, PhD

  • Director / Pharmacist, Ministry of Food and Drug Safety
  • National Institute of Food and Drug Safety Evaluation (NIFDS), Korea, Republic of

Contact us

Please contact DIA Japan for further information.

Send Email
+81.3.6214.0574